Brainstorm Cell Therapeutics, Inc. (BCLI)
1.07
-0.18
(-14.40%)
USD |
OTCM |
Sep 03, 16:00
Brainstorm Cell Therapeutics Accounts Payable (Quarterly) : 7.488M for June 30, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.488M |
| March 31, 2026 | 7.317M |
| December 31, 2025 | 7.067M |
| September 30, 2025 | 6.42M |
| June 30, 2025 | 5.997M |
| March 31, 2025 | 6.797M |
| December 31, 2024 | 6.08M |
| September 30, 2024 | 4.603M |
| June 30, 2024 | 5.34M |
| March 31, 2024 | 4.69M |
| December 31, 2023 | 4.954M |
| September 30, 2023 | 3.926M |
| June 30, 2023 | 5.19M |
| March 31, 2023 | 7.802M |
| December 31, 2022 | 6.224M |
| September 30, 2022 | 6.395M |
| June 30, 2022 | 5.292M |
| March 31, 2022 | 4.57M |
| December 31, 2021 | 3.70M |
| September 30, 2021 | 2.739M |
| June 30, 2021 | 3.00M |
| March 31, 2021 | 2.552M |
| December 31, 2020 | 5.417M |
| September 30, 2020 | 3.283M |
| June 30, 2020 | 4.604M |
| Date | Value |
|---|---|
| March 31, 2020 | 4.571M |
| December 31, 2019 | 14.68M |
| September 30, 2019 | 9.144M |
| June 30, 2019 | 8.765M |
| March 31, 2019 | 5.029M |
| December 31, 2018 | 4.548M |
| September 30, 2018 | 2.602M |
| June 30, 2018 | 4.182M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.275M |
| June 30, 2017 | 0.227M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 1.304M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.326M |
Accounts Payable Definition
Represents amounts due to suppliers of goods and/or services used in the company's operations, generally not interest-bearing, and as yet unpaid at the prior fiscal period-end and expected to be paid within the current period. Data for this field is generally not available prior to 1989.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| NovelStem International Corp. | 0.00 |
| Summit Therapeutics, Inc. | 22.90M |
| Kezar Life Sciences, Inc. | 0.273M |
| Protara Therapeutics, Inc. | 4.663M |
| Clene, Inc. | 1.142M |